@gruenenthal.com
Grünenthal is a global leader in pain management and related diseases.
📢
Find anything inaccurate?
If you spot any mistakes on this brand profile, report to us.
Brand Logos
View allLogo
SVG
Icon
JPEG
About
Description
Grunenthal is a pharmaceutical company based in Germany. It was established in 1946 by Hermann Wirtz and his son, Hubert, in Aachen, Germany. Initially, the company focused on the production of herbal remedies and vitamins.
However, over time, it expanded its product portfolio to include various therapeutic areas such as pain relief, psychiatry, and gastroenterology. The company's headquarters are located in Aachen, Germany. It houses various departments including research and development, manufacturing, sales, and marketing.
The headquarters serve as the central hub for the company's global operations. Grunenthal offers a wide range of products and services in the pharmaceutical industry. Its main products include painkillers, opioid analgesics, drugs for central nervous system disorders, and treatments for inflammatory diseases.
The company is committed to developing innovative and effective medications that improve the lives of patients worldwide. On a global scale, Grunenthal operates in more than 30 countries, with subsidiaries and production facilities in various parts of the world. It has established joint ventures and partnerships with other pharmaceutical companies to expand its reach and capabilities.
One notable subsidiary is Mundipharma, which operates in Asia, Europe, Latin America, and the Middle East. In terms of market position, Grunenthal is a key player in the pharmaceutical industry. It has a strong presence in Europe and is continuously expanding its market share globally.
The company has a competitive edge due to its focus on research and development, as well as its commitment to providing high-quality medications. Over the years, Grunenthal has achieved several significant milestones. In 1977, the company developed Tramadol, a widely used pain medication.
In recent years, Grunenthal has focused on strengthening its pipeline by investing in research projects and collaborations. As of the latest available information, Grunenthal continues to grow and innovate in the pharmaceutical industry. It maintains a strong global presence and is dedicated to improving patient outcomes through its products and services.
The company constantly adapts to the changing market needs and strives to expand its market position
Brand collections
View allLogos
Colors
Fonts
Images
Our mission is to keep every brand on-brand everywhere 👋
All services online